CSRXP: OUTRAGEOUS PRICE TAG ON NEW DIABETES DRUG LATEST EXAMPLE OF BIG PHARMA’S OUT-OF-CONTROL LAUNCH PRICES
Nov 21, 2022
Drug Company Sets Nearly $200,000 Price on Newly Approved Treatment for Type 1… Read More
© 2024 CSRXP- All Rights Reserved
Updates
CSRXP APPLAUDS FDA APPROVAL OF SECOND INTERCHANGEABLE BIOSIMILAR FOR INSULIN
Nov 18, 2022
Interchangeable Biosimilars Help Provide Patients with Greater Choice and More… Read More
TWO BIRDS OF A FEATHER: BIG PHARMA COMPANIES EYE MERGER TO UNDERMINE GENERIC COMPETITION TO OPIOID TREATMENTS
Nov 16, 2022
Brand Name Drug Company to Acquire Manufacturer of Narcan as Both Work to… Read More
BIG PHARMA EARNINGS WATCH: GLAXOSMITHKLINE, AMGEN, ASTRAZENECA
Nov 11, 2022
Big Pharma Giants Notch Expectation-Busting Earnings After Continuing to Hike… Read More
BIG PHARMA EARNINGS WATCH: PFIZER, ABBVIE, SANOFI, ELI LILLY
Nov 4, 2022
Big Pharma Giants Beat Wall Street Expectations After Year of Price Increases,… Read More
BIG PHARMA WATCH: REPRESENTATIVE KATIE PORTER HIGHLIGHTS BIG PHARMA’S OUTRAGEOUS CANCER DRUG LAUNCH PRICES
Nov 3, 2022
New Report Finds Brand Name Drug Companies Increased Prices on New Oncology… Read More
DOSE OF REALITY: NEW STUDY UNDERSCORES BIG PHARMA’S PRICING PRACTICES ARE ABOUT PROFITS, NOT VALUE FOR PATIENTS
Nov 1, 2022
JAMA Analysis Finds No Correlation Between Cancer Drug Prices and… Read More
BIG PHARMA EARNINGS WATCH: MERCK, BRISTOL MYERS SQUIBB, NOVARTIS
Oct 28, 2022
New Earnings Reports Show Big Pharma Giants Basking in Massive Profits,… Read More
BIG PHARMA WATCH: DRUG MAKER PRICES CHEMO TREATMENT TEN TIMES ABOVE THE MARKET AS PATIENTS FACE SHORTAGES
Oct 28, 2022
Areva Pharmaceuticals Price-Gouges Cancer Patients Who Rely on Older Oncology… Read More
CSRXP: PFIZER’S EGREGIOUS VACCINE PRICE HIKE DEMONSTRATES URGENCY TO BUILD ON POSITIVE PROGRESS TO HOLD BIG PHARMA ACCOUNTABLE
Oct 21, 2022
Big Pharma Companies Want to Price-Gouge the American People and Health Care… Read More
BIG PHARMA WATCH: BIG PHARMA’S EGREGIOUS PRICING PRACTICES FORCE MORE THAN ONE MILLION AMERICANS TO RATION INSULIN DUE TO COST
Oct 20, 2022
The Problem with Insulin Affordability is the Price, Driven by “Shadow… Read More
BIG PHARMA EARNINGS WATCH: JOHNSON & JOHNSON
Oct 19, 2022
J&J Beats Q3 Earnings Expectations After Dozens of Prescription Drug Price… Read More